Login / Signup

Interleukin-1α as a Potential Prognostic Biomarker in Pancreatic Cancer.

Leonardo GiganteGwladys Gaudillière-Le DainAurélie BertautCaroline TruntzerFrançois Ghiringhelli
Published in: Biomedicines (2024)
is an independent prognostic marker and could be considered a potential therapeutic target in pancreatic cancer patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • patient reported outcomes
  • climate change